191 related articles for article (PubMed ID: 29915642)
1. Patient Preferences and Therapeutic Satisfaction with Topical Agents for Rosacea: A Survey-Based Study.
Williamson T; Cheng WY; McCormick N; Vekeman F
Am Health Drug Benefits; 2018 Apr; 11(2):97-106. PubMed ID: 29915642
[TBL] [Abstract][Full Text] [Related]
2. Concerns and Treatment Satisfaction in Patients Being Treated With Azelaic Acid Foam for Rosacea.
Williamson T; Cameron J; McLeod K; Turner B; Quillen A; LaRose A; Lott J; Gaiser A
J Drugs Dermatol; 2019 Apr; 18(4):381-386. PubMed ID: 31013011
[TBL] [Abstract][Full Text] [Related]
3. Interventions for rosacea.
van Zuuren EJ; Fedorowicz Z; Carter B; van der Linden MM; Charland L
Cochrane Database Syst Rev; 2015 Apr; 2015(4):CD003262. PubMed ID: 25919144
[TBL] [Abstract][Full Text] [Related]
4. A comparison of topical azelaic acid 20% cream and topical metronidazole 0.75% cream in the treatment of patients with papulopustular rosacea.
Maddin S
J Am Acad Dermatol; 1999 Jun; 40(6 Pt 1):961-5. PubMed ID: 10365928
[TBL] [Abstract][Full Text] [Related]
5. Rosacea Treatment Satisfaction: Matching Adjusted Indirect Treatment Comparison Analysis of Metronidazole Gel or Cream vs Azelaic Acid Foam.
Williamson T; LaRose A; Cameron J; Lott J; Eaddy M; Hopson S; Shih HC; Tennant LT
J Drugs Dermatol; 2020 Mar; 19(3):295-304. PubMed ID: 32550696
[TBL] [Abstract][Full Text] [Related]
6. Cost-Effectiveness of Ivermectin 1% Cream in Adults with Papulopustular Rosacea in the United States.
Taieb A; Stein Gold L; Feldman SR; Dansk V; Bertranou E
J Manag Care Spec Pharm; 2016 Jun; 22(6):654-65. PubMed ID: 27231793
[TBL] [Abstract][Full Text] [Related]
7. Open-label study assessing the efficacy and tolerability of topical skin care and sun protection alone and in combination with intense pulsed light therapy.
Deaver Peterson J; Katz TM
J Cosmet Dermatol; 2019 Dec; 18(6):1758-1764. PubMed ID: 31017734
[TBL] [Abstract][Full Text] [Related]
8. Comparative study of some treatment modalities of rosacea.
Mostafa FF; El Harras MA; Gomaa SM; Al Mokadem S; Nassar AA; Abdel Gawad EH
J Eur Acad Dermatol Venereol; 2009 Jan; 23(1):22-8. PubMed ID: 18705632
[TBL] [Abstract][Full Text] [Related]
9. Efficacy of topical ivermectin and impact on quality of life in patients with papulopustular rosacea: A systematic review and meta-analysis.
Husein-ElAhmed H; Steinhoff M
Dermatol Ther; 2020 Jan; 33(1):e13203. PubMed ID: 31863543
[TBL] [Abstract][Full Text] [Related]
10. A comparison of 15% azelaic acid gel and 0.75% metronidazole gel in the topical treatment of papulopustular rosacea: results of a randomized trial.
Elewski BE; Fleischer AB; Pariser DM
Arch Dermatol; 2003 Nov; 139(11):1444-50. PubMed ID: 14623704
[TBL] [Abstract][Full Text] [Related]
11. Inadequate Disease Control, Treatment Dissatisfaction, and Quality-of-Life Impairments Among US Patients Receiving Topical Therapy for Atopic Dermatitis.
Anderson P; Austin J; Lofland JH; Piercy J; Joish VN
Dermatol Ther (Heidelb); 2021 Oct; 11(5):1571-1585. PubMed ID: 34268709
[TBL] [Abstract][Full Text] [Related]
12. Objective severity does not capture the impact of rosacea, acne scarring and photoaging in patients seeking laser therapy.
Thomas CL; Kim B; Lam J; Richards S; See A; Kalouche S; Paver RD; Fernández Peñas P
J Eur Acad Dermatol Venereol; 2017 Feb; 31(2):361-366. PubMed ID: 27640402
[TBL] [Abstract][Full Text] [Related]
13. The efficacy, safety, and tolerability of ivermectin compared with current topical treatments for the inflammatory lesions of rosacea: a network meta-analysis.
Siddiqui K; Stein Gold L; Gill J
Springerplus; 2016; 5(1):1151. PubMed ID: 27504249
[TBL] [Abstract][Full Text] [Related]
14. Update on the management of rosacea.
Weinkle AP; Doktor V; Emer J
Clin Cosmet Investig Dermatol; 2015; 8():159-77. PubMed ID: 25897253
[TBL] [Abstract][Full Text] [Related]
15. Efficacy and safety of once-daily metronidazole 1% gel compared with twice-daily azelaic acid 15% gel in the treatment of rosacea.
Wolf JE; Kerrouche N; Arsonnaud S
Cutis; 2006 Apr; 77(4 Suppl):3-11. PubMed ID: 16706244
[TBL] [Abstract][Full Text] [Related]
16. Update on the Management of Rosacea.
Weinkle AP; Doktor V; Emer J
Plast Surg Nurs; 2015; 35(4):184-202. PubMed ID: 26605825
[TBL] [Abstract][Full Text] [Related]
17. Topical metronidazole. A review of its use in rosacea.
McClellan KJ; Noble S
Am J Clin Dermatol; 2000; 1(3):191-9. PubMed ID: 11702300
[TBL] [Abstract][Full Text] [Related]
18. Topical metronidazole maintains remissions of rosacea.
Dahl MV; Katz HI; Krueger GG; Millikan LE; Odom RB; Parker F; Wolf JE; Aly R; Bayles C; Reusser B; Weidner M; Coleman E; Patrignelli R; Tuley MR; Baker MO; Herndon JH; Czernielewski JM
Arch Dermatol; 1998 Jun; 134(6):679-83. PubMed ID: 9645635
[TBL] [Abstract][Full Text] [Related]
19. Interventions for rosacea based on the phenotype approach: an updated systematic review including GRADE assessments.
van Zuuren EJ; Fedorowicz Z; Tan J; van der Linden MMD; Arents BWM; Carter B; Charland L
Br J Dermatol; 2019 Jul; 181(1):65-79. PubMed ID: 30585305
[TBL] [Abstract][Full Text] [Related]
20. Interventions for rosacea.
van Zuuren EJ; Kramer S; Carter B; Graber MA; Fedorowicz Z
Cochrane Database Syst Rev; 2011 Mar; (3):CD003262. PubMed ID: 21412882
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
